摘要
目的研究腺苷(adenosine)对嘌呤受体P2X7和谷氨酸N-甲基-D-天冬氨酸(NMDA)受体激活诱导的大鼠视网膜神经节细胞(RGC)死亡的神经保护作用。方法(1)对新生Long-Evan大鼠进行上丘注射荧光标记物荧光金(aminostilbamidine)以标记RGC,检测P2X7激动剂BzATP(50μmol/L)、谷氨酸NMDA受体激动剂(100μmol/L)和腺苷(300μmol/L)对体外培养RGC存活率的影响;(2)体外培养未经荧光金标记的新生大鼠RGC,以10μmol/L钙离子(Ca^2+)荧光染料Fura-2乙酸甲酯(Fura-2Am)标记后,利用Ca^2+影像测定仪分别测定BzATP、NMDA和腺苷对RGC内Ca^2+浓度的影响。结果BzATP和NMDA均可引起体外培养的RGC死亡,BzATP在50μmol/L、NMDA在100μmol/L浓度下,均杀死约30%RGC。而300μmol/L腺苷则可明显减轻两者对RGC的毒性作用,使RGC存活率分别从68.9%±2.3%、69.9%±3.2%提高至91.2%±3.5%(P〈0.001)、102.1%±3.9%(P〈0.001)。BzATP可引起RGC内Ca^2+持续升高,在50μmol/L浓度下可使细胞内Ca^2+升高至(1183±109)nmol/L。在300μmol/L腺苷作用下,BzATP介导的Ca^2+升高幅度显著降低,仅升高为(314±64)nmol/L(P〈0.001)。结论腺苷能阻止P2X,受体和NMDA受体激活诱导的RGC死亡和细胞内钙离子浓度升高,具有神经保护作用。
Objective To evaluate the inhibiting effect of adenosine on rat retinal ganglion cells (RGC) death induced by P2X7 and N-methyl-D-aspartate (NMDA) receptor. Methods (1) Long-Evan neonatal rats were back labeled with aminostilbamidine to identify RGC. The viability of RGC affected by P2X7 excitomotor BzATP (50 μmol/L), glutamate receptor exeitomotor NMDA (100 μmol/L) and adenosine (300 μmol/L) was detected. (2) RGC from the retinae of unlabeled neonatal rats were cultured in vitro. After labeled with Fura-2 methyl acetate, an intracellular calcium indicator, the effect of BzATP, NMDA and adenosine on intracellular Ca2+ level was detected by Ca^2+ imaging system. Results Both BzATP (50 μmol/L) and NMDA (100 μmol/L) could kill about 30% of the RGC. Cell death was prevented by adenosine (300 μmol/L) with the cell viability increased from (68.9±2.3)% and (69.9±3.2)% to (91.2±3.5)% (P〈0.001) and (102.1±3.9)% (P〈0.001), respectively. BzATP (50 μmol/L) led to a large, sustained increase of intraeellular Ca^2+ concentration to (1183±109) nmol/L. After the adenosine intervened, Ca^2+ concentration increased slightly to (314±64) nmol/L (P〈0. 001). Conclusion Adenosine may prevent RGC death and increase of intracellular Ca^2+ concentration from P2X7-and NMDA receptor stimulation.
出处
《中华眼底病杂志》
CAS
CSCD
北大核心
2007年第2期133-136,共4页
Chinese Journal of Ocular Fundus Diseases
基金
广东省科技计划国际合作项目(2006B60501003)
广州市科技计划项目(2006J1-C0051)